This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Sumitomo Pharma Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Christian Klaus Herz: Innovator in Pharmaceutical Chemistry
Introduction
Christian Klaus Herz is a notable inventor based in Neuendettelsau, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patent work. His expertise and dedication to research have led to advancements in drug formulation and treatment methods.
Latest Patents
Christian Klaus Herz holds a patent for "Crystalline solvated forms of N-(4-(1-(2,6-difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-methoxy-3-pyridazinyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-N'-methoxyurea." This disclosure relates to crystalline solvated forms of the compound, as well as methods for making these forms, pharmaceutical compositions, and kits that include them. The patent also covers methods of treatment and uses involving the administration of these crystalline forms.
Career Highlights
Throughout his career, Christian Klaus Herz has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Sumitomo Pharma Co., Ltd. and Medivation Technologies, Inc. His work in these organizations has contributed to the development of innovative pharmaceutical solutions.
Collaborations
Christian has collaborated with several professionals in his field, including Carsten Jagusch and Andreas Schrodt. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Christian Klaus Herz is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable advancements in drug formulation. His contributions through patents and collaborations highlight his commitment to improving healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile